13th Vitreoretinal Symposium – VRS Plus 2011
Scientific programm: Symposium
Saturday, 14th May 2011 — 11.50 - 13.05
5th scientific session:
AMD, Diabetics and Veins I
Chairmen and moderation:
Albert J. Augustin, Karlsruhe (Germany)
Paul B. Griggs, Seattle (USA)
|
| 35 |
Thomas Keune, Heidelberg Engineering, Heidelberg (Germany)
Significance of SD OCT for individualized anti VEGF therapy |
| 36 |
Michael J. Koss, Frankfurt/Main (Germany)
Intraocular Cytokines correlated with Spectral OCT
in neovascular AMD |
| 37 |
Albert J. Augustin, Karlsruhe (Germany)
PDT for wet AMD – Adjunctive therapy maybe helpful;
What is the first-line treatment of macular edema in diabetes
when coming from pathophysiology and pathobiochemistry? |
| 38 |
Stephen H. Sinclair, Media (USA)
Procrit and CSDME, RVO and/or atrophic AMD |
| 39 |
Ron A. Adelman, New Haven (USA)
Management of neovascular AMD in 2011 |
| 40 |
Ron A. Adelman, New Haven (USA)
VEGF Trap for AMD |
| 41 |
Albert J. Augustin, Karlsruhe (Germany)
Diabetic macular edema (DME)- Surgical Approach to the
Vitreoretinal Interface |
| 42 |
Birgit Böhm, Octreopharm, Köln (Germany)
Epimacular Brachytherapy: New hope for patients with wet AMD |
| |
|
| 13.05 |
Panel Discussion
Moderators:
L. Fischer, New York (USA)
Ron A. Adelman, New Haven (USA) |
| |
|
| 13.25 |
Lunch Break in the industrial exhibition area
NOVARTIS invites you to lunch |
Copyright © VRS-online, 1999-.
All rights reserved. Impressum, rechtliche Hinweise
HTML & Webdesign: SPALLEK.COM